Evidence map›Paper›PMID 33191465›Full record

ArticleAmino acids2020

Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies.

Aleksandra Tencheva, Rui Liu, Tatyana V Volkova, Radoslav Chayrov, Yavor Mitrev, Martin Štícha, Yuhuan Li, Hailun Jiang, Zhuorong Li, Ivanka Stankova and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Amino acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Novel topical treatment for dysgeusia/ageusia: a case series report.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Aleksandra TenchevaDepartment of Chemistry, South-West University "Neofit Rilski", 2700, Blagoevgrad, Bulgaria.
Rui LiuInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Tatyana V VolkovaKrestov's Institute of Solution Chemistry, Russian Academy of Sciences, 153045, Ivanovo, Russia.
Radoslav ChayrovDepartment of Chemistry, South-West University "Neofit Rilski", 2700, Blagoevgrad, Bulgaria.
Yavor MitrevInstitute of Organic Chemistry With Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bontchev Str. Bl. 9, 1113, Sofia, Bulgaria.
Martin ŠtíchaDepartment of Chemistry, Faculty of Science, Charles University in Prague, 128 43, Prague 2, Czech Republic.
Yuhuan LiInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Hailun JiangInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Zhuorong LiInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Ivanka StankovaDepartment of Chemistry, South-West University "Neofit Rilski", 2700, Blagoevgrad, Bulgaria. ivastankova@abv.bg.ORCID http://orcid.org/0000-0002-2750-5813
German L PerlovichKrestov's Institute of Solution Chemistry, Russian Academy of Sciences, 153045, Ivanovo, Russia. glp@isc-ras.ru.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNSouth-West University "Neofit Rilski" · BGInstitute of Solution Chemistry · RUBulgarian Academy of Sciences · BGCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug compounds including memantine moieties are an important group of biologically active agents for different pathologies, including the Alzheimer's disease. In the present study, a series of memantine derivatives incorporating amino acid residues have been synthesized and their neuroprotective in vitro evaluation in respect of the Alzheimer's disease, involving the effects on the resistance to Aβ toxicity, excitotoxicity, oxidative stress, hypoxia, and neuroinflammation has been studied. The cytotoxicities of the compounds were detected by CPE assay. TC

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsDogsGlutamic AcidHumansInfluenza, HumanMadin Darby Canine Kidney CellsMemantineNeuroprotective AgentsOrthomyxoviridaeOxidative StressAmyloid beta-PeptidesGlutamic AcidMemantineNeuroprotective AgentsAlzheimer’s diseaseAmino acidsMemantine

Identifiers

PMID33191465
OpenAlexW3103866240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.